Claims
- 1. A novel (fused) benz(thio)amide of the general formula: ##STR394## wherein A represents a single bond or a group of methylene, ethylene, trimethylene, tetramethylene, vinylene, propenylene, butenylene, butadienylene or ethynylene group optionally being substituted by one, two or three of straight or branched alkyl group(s) of from 1 to 10 carbon atom(s) and/or phenyl group(s);
- B repesents a heterocyclic ring of from 4 to 8 members containing one, two or three hetero atom(s) selected from the group consisting of oxygen, nitrogen and sulphur atom(s), wherein the said ring may optionally be substituted by group(s) selected from oxo, thioxo and/or hydroxy group(s) with the exclusion of a ring of formula: ##STR395## T represents an oxygen atom or a sulphur atom; R.sup.1 represents a group of general formula:
- (i) ##STR396## (iii) ##STR397## or (ii) ##STR398## or (iv) a straight or branched alkyl, alkenyl or alkynyl group of from 1 to 20 carbon atom(s), wherein R.sup.5 and R.sup.6 independently represent a hydrogen atom or a halogen atom or a straight or branched alkyl, alkenyl or alkynyl group of from 1 to 20 carbon atom(s) being unreplaced or replaced by one, two, three, four or five optional carbon atom(s), by oxygen atom(s), sulphur atom(s), halogen atom(s), nitrogen atom(s), benzene ring(s), thiophene ring(s), naphthalene ring(s), carbocyclic ring(s) of from 4 to 7 carbon atom(s), carbonyl group(s), carbonyloxy group(s), hydroxy group(s), carboxy group(s), azido group(s) and/or nitro group(s);
- R.sup.2 represents a hydrogen atom or a straight or branched alkyl group of from 1 to 6 carbon atom(s);
- R.sup.3 represents a hydrogen atom, a halogen atom, a hydroxy group, a nitro group, a group of general formula: --COOR.sup.7, wherein R.sup.7 represents a hydrogen atom or a straight or branched alkyl group of from 1 to 6 carbon atom(s), or a straight or branched alkyl, alkoxy or alkylthio group of from 1 to 6 carbon atom(s);
- R.sup.4 represents a group of general formula: ##STR399## wherein U represents an oxygen atom or a sulphur atom, R.sup.8 represents a hydrogen atom or a straight or branched alkyl group of from 1 to 6 carbon atom(s), n and m represent an integer of from 1 to 10, respectively, p and q represent zero or an integer of from 1 to 10, respectively, or
- non-toxic salts thereof.
- 2. A compound according to claim 1 wherein the symbol B is a ring of formula: ##STR400## wherein the rings may optionally be substituted by hydroxy group(s).
- 3. A compound according to claim 2,
- wherein B is 2,3-dihydrofuran ring, i.e., the formula: ##STR401##
- 4. A compound according to claim 3,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 5. A compound according to claim 4,
- wherein R.sup.1 is a group of the general formula: ##STR402## (wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1).
- 6. A compound according to claim 5,
- which is selected from the group consisting of
- 7-(p-hexyloxybenzoyl)amino-2-(5-tetrazolyl)benzofuran,
- 7-(p-octyloxybenzoyl)amino-2-(5-tetrazolyl)benzofuran,
- 7-(p-heptyloxybenzoyl)amino-2-(5-tetrazolyl)benzofuran,
- 7-(p-nonyloxybenzoyl)amino-2-(5-tetrazolyl)benzofuran,
- 7-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)benzofuran,
- 7-[p-(2E,7-octadienyl)benzoyl]amino-2-(5-tetrazolyl)benzofuran,
- 7-[p-(6-chlorohexyloxy)benzoyl]amino-2-(5-tetrazolyl)benzofuran and
- 7-(p-pentylcinnamoyl)amino-2-(5-tetrazolyl)benzofuran
- and sodium salts thereof.
- 7. A compound according to claim 2,
- wherein B is 2,3,4,5-tetrahydrofuran ring, i.e., the formula: ##STR403##
- 8. A compound according to claim 7,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 9. A compound according to claim 8,
- wherein R.sup.1 is a group of the general formula: ##STR404## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 10. A compound according to claim 9,
- which is selected from the group consisting of
- 7-(p-hexyloxybenzoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1-benzofuran,
- 7-(p-heptyloxybenzoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1-benzofuran,
- 7-(p-octyloxybenzoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1-benzofuran,
- 7-(p-nonyloxybenzoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1-benzofuran, and
- 7-(p-pentylcinnamoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1-benzofuran
- and sodium salts thereof.
- 11. A compound according to claim 2,
- wherein B is pyridine ring optionally being substituted by hydroxy group(s), i.e., the formula: ##STR405##
- 12. A compound according to claim 11,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 13. A compound according to claim 12,
- wherein R.sup.1 is a group of the general formula: ##STR406## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 14. A compound according to claim 13,
- which is selected from the group consisting of
- 8-[p-(2E,7-octadienyloxy)benzoyl]amino-2-(5-tetrazolyl)quinoline,
- 8-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)quinoline,
- 8-[p-(6-chlorohexyloxy)benzoyl]amino-2-(5-tetrazolyl)quinoline,
- 8-[p-(2E,7-octadienyloxy)benzoyl]amino-4-hydroxyquinoline-2-carboxylic acid,
- 8-[p-(4-phenylbutoxy)benzoyl]amino-4-hydroxyquinoline-2-carboxylic acid,
- 8-[p-[4-(2-thienyl)butoxy]benzoyl]amino-4-hydroxyquinoline-2-carboxylic acid,
- 8-[p-(2E,7-octadienyloxy)benzoyl]amino-4-hydroxy-2-(5-tetrazolyl)quinoline,
- 8-[p-(4-phenylbutoxy)benzoyl]amino-4-hydroxy-2-(5-tetrazolyl)quinoline and
- 8-(p-pentylcinnamoyl)amino-4-hydroxy-2-(5-tetrazolyl)quinoline
- and sodium salts thereof.
- 15. A compound according to claim 2,
- wherein B is 4,5-dihydrodioxole ring, i.e., the formula: ##STR407##
- 16. A compound according to claim 15,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 17. A compound according to claim 16,
- wherein R.sup.1 is a group of the general formula: ##STR408## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 18. A compound according to claim 17,
- which is selected from the group consisting of
- 4-(p-heptyloxybenzoyl)amino-2-(5-tetrazolyl)-1,3-benzodioxole,
- 4-(p-hexyloxybenzoyl)amino-2-(5-tetrazolyl)-1,3-benzodioxole,
- 4-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-1,3-benzodioxole, and
- 4-(p-pentylcinnamoyl)amino-2-(5-tetrazolyl)-1,3-benzodioxole
- and sodium salts thereof.
- 19. A compound according to claim 2,
- wherein B is 2,3,6,7-tetrahydro-5H-1,4-dioxepin ring, i.e., the formula: ##STR409##
- 20. A compound according to claim 19,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 21. A compound according to a claim 20,
- wherein R.sup.1 is a group of the general formula: ##STR410## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 22. A compound according to claim 21,
- which is selected from the group consisting of
- 9-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-3,4-dihydro-2H-1,5-benzodioxepin,
- 9-[p-(2E,7-octadienyloxy)benzoyl]amino-2-(5-tetrazolyl)-3,4-dihydro-2H-1,5-benzodioxepin and
- 9-[p-(7-octenyloxy)benzoyl]amino-2-(5-tetrazolyl)-3,4-dihydro-2H-1,5-benzodioxepin
- and sodium salts thereof.
- 23. A compound according to claim 2,
- wherein B is morpholine ring, i.e., the formula: ##STR411##
- 24. A compound according to claim 23,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 25. A compound according to claim 24,
- wherein R.sup.1 is a group of the general formula: ##STR412## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 26. A compound according to claim 25,
- which is selected from the group consisting of
- 8-(p-heptyloxybenzoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1,4-benzoxazine,
- 8-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-2,3-dihydro-1,4-benzoxazine and
- 8-(p-pentylcinnamoyl)amino-2-(5-tetrazolyl)-2,3-dihydro-1,4-benzoxazine
- and sodium salts thereof.
- 27. A compound according to claim 2,
- wherein B is 3,4,5,6-tetrahydro-2H-pyran ring, i.e., the formula: ##STR413##
- 28. A compound according to claim 27,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 29. A compound according to claim 28,
- wherein R.sup.1 is a group of the general formula: ##STR414## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 30. A compound according to claim 29,
- which is selected from the group of consisting of
- 8-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-3,4-dihydro-2H-1-benzopyran and
- 8-[p-(7-octenyloxy)benzoyl]amino-2-(5-tetrazolyl)-3,4-dihydro-2H-1-benzopyran
- and sodium salts thereof.
- 31. A compound according to claim 2,
- wherein B is 2,3-dihydro-4-oxo-1-thiopyran ring, i.e., the formula: ##STR415##
- 32. A compound according to claim 31,
- wherein A is a single bond or vinylene group being unsubstituted or substituted by straight or branched alkyl group(s) of from 1 to 6 carbon atom(s) or phenyl group(s) and T is an oxygen atom.
- 33. A compound according to claim 32,
- wherein R.sup.1 is a group of the general formula: ##STR416## wherein R.sup.5 and R.sup.6 are the same meaning as depicted in claim 1.
- 34. A compound according to claim 33,
- which is 8-[p-(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzothiopyran or sodium salt thereof.
- 35. A pharmaceutical composition characterised by comprising as active ingredient at least one compound of the general formula (I) depicted in claim 1 wherein various symbols are as defined in claim 1, or non-toxic salt thereof, together with a pharmaceutical carrier and/or coating.
Priority Claims (3)
Number |
Date |
Country |
Kind |
59-172570 |
Aug 1984 |
JPX |
|
59-243412 |
Dec 1984 |
JPX |
|
59-246363 |
Dec 1984 |
JPX |
|
Parent Case Info
This is a division of application Ser. No. 207,994, filed June 17, 1988, now U.S. Pat. No. 4,847,275, which is a division of application Ser. No. 767,538 filed Aug. 20, 1985 now U.S. Pat. No. 4,780,469.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3549689 |
Frey et al. |
Dec 1970 |
|
Divisions (2)
|
Number |
Date |
Country |
Parent |
207994 |
Jun 1988 |
|
Parent |
767538 |
Aug 1985 |
|